TWi T210 15mg Pill - clear white capsule/oblong
Pill with imprint TWi T210 15mg is Clear / White, Capsule/Oblong and has been identified as Topiramate 15 mg. It is supplied by TWi Pharmaceuticals, Inc.
Topiramate is used in the treatment of Lennox-Gastaut Syndrome; Migraine Prevention; Seizures; Epilepsy; Seizure Prevention and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TWi T210 15mg
Topiramate
- Imprint
- TWi T210 15mg
- Strength
- 15 mg
- Color
- Clear / White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- TWi Pharmaceuticals, Inc.
- Manufacturer
- Bora Pharmaceutical Laboratories Inc.
- National Drug Code (NDC)
- 24979-0210
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,329)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.